GYGuojian Yin

Guojian Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guojian Yin has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Zhou

    Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, No.1055, San-xiang Road, Gu-su District, Suzhou, China

    10 shared publications
  • Yuxin Liu

    Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, No.1055, San-xiang Road, Gu-su District, Suzhou, China

    7 shared publications
  • Shuqi Qin

    Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, No.1055, San-xiang Road, Gu-su District, Suzhou, China

    6 shared publications
  • Si Dai

    Department of Gastroenterology, Songtao Miao Autonomous County People’s Hospital, Guizhou Province, China

    6 shared publications
  • Wen Tang

    Soochow Univ, Affiliated Hosp 2, Digest Dept, Suzhou 215004, Peoples R China

    5 shared publications
  • Zhendan Wang

    Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, No.1055, San-xiang Road, Gu-su District, Suzhou, China

    4 shared publications

Latest Publications

  • Open Access

    The Efficacy of Early Magnesium Sulphate Catharsis in Potential Severe Acute Pancreatitis: A Clinical Cohort Study

    by Guojian Yin, Yuxin Liu, Heng Yang, Jiaming Wu, Shuqi Qin, Si Dai, Li Cui, Jing Zhou, Jiujing Huang, Fengjie Ji, et al.

    Background and Aims: Acute pancreatitis (AP) can lead to systemic inflammatory response (SIRS), paralytic intestinal obstruction, and in severe cases, intra-abdominal hypertension (IAH), organ failure (OF), and even death. Early magnesium sulphate (MS) catharsis treatment can relieve paralytic intestinal obstruction and IAH, thus reducing the incidence of severe acute pancreatitis (SAP) as well as mortality. Methods: 850 patients with AP at high risk of systemic complications (potential SAP (p-SAP)) were recruited. These p-SAP patients were categorized into two groups based on the treatment they received: the routine group (RT group, standard treatment for AP) and the MS group (early MS catharsis added to standard treatment). The final cohort had an allocation ratio of 2.5:1 (RT : MS). The primary composite endpoints were clinically finally diagnosed SAP (d-SAP) and mortality. The intensive care unit (ICU) admission, OF, inflammatory factors, length of hospital stay, and hospitalization costs, etc. were also compared and analyzed. Results: It demonstrated that early MS catharsis treatment was highly effective in preventing patients with p-SAP of various aetiologies from deteriorating to d-SAP and reducing their mortality significantly. In addition, it significantly reduced the incidence of OFs, pancreatic necrosis, ICU admissions, CRRT utilisation, and the cost and length of stay of hospitalisation for these patients. Conclusions: It showed that early MS catharsis had a significant therapeutic effect on p-SAP patients, which would profoundly contribute to the clinical management of AP.

  • Open Access

    Sex-specific associations of SHBG, testosterone, and obesity with cholecystectomy risk: a population-based cohort study

    by Jie-Qiong Lyu, Yi Luo, Yu-Wen Qian, Ji-Mei Gu, Meng-Yuan Miao, Guo-Chong Chen, Guo-Jian Yin

    Background: Gallstone disease exhibits a marked sex difference. While obesity and female sex hormones are known risk factors, the role of sex hormone-binding globulin (SHBG) and testosterone in gallstone-related risk, and whether they mediate the association between obesity and gallbladder disease, remain unclear. Methods: We included 176,909 men and 160,147 women from the UK Biobank. Serum SHBG and testosterone were measured using immunoassays. Incident cholecystectomy cases were identified through hospital records. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs). Mediation analyses were performed to assess the contribution of SHBG and testosterone to the obesity-cholecystectomy association. Results: A total of 2,877 men and 4,607 women underwent cholecystectomy. Higher SHBG levels were associated with a lower risk of cholecystectomy in both sexes, with a stronger association in women (HR Q4 vs. Q1 = 0.40, 95% CI: 0.36–0.43) than in men (HR Q4 vs. Q1 = 0.67, 95% CI: 0.59–0.77). Elevated testosterone levels were associated with an increased risk of cholecystectomy only in women (HR Q4 vs. Q1 = 1.28; 95% CI: 1.18–1.38). Obesity exhibited a stronger association with cholecystectomy in women than in men. In women, SHBG mediated 14.7% and 20.0% of the associations between general and abdominal obesity and cholecystectomy, respectively, whereas testosterone mediated smaller proportions (2.7% and 1.8%). No significant mediation was observed in men. Conclusions: SHBG levels are inversely associated with risk of cholecystectomy in both sexes, whereas higher testosterone levels are associated with a higher risk of cholecystectomy only in women. SHBG and, to a lesser extent, testosterone accounted for a modest proportion of the obesity-cholecystectomy association in women.

  • Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

    by Shu-Qi Qin, Yu-Xin Liu, Zhen-Dan Wang, Si Dai, Jing Zhou, Ke-Wei Hu, Qin-Kai Li, Guo-Jian Yin

    The underwater technique is an important innovation in gastrointestinal endoscopy, which has been used for the treatment of colonic lesions, esophageal, and gastric neoplasms. Endoscopic injection sclerotherapy (EIS) is a safe and effective way to treat and prevent gastroesophageal variceal bleeding (GEVB). However, paravascular submucosal injection may result in the failure of the procedure, bleeding esophageal ulcers, or esophageal stenosis. Esophageal peristalsis is an important problem when the endoscopist injects the sclerosant into the varices. This may cause the needle inside the vein to become unstable and be removed, and the endoscopic vision may become unclear during injection. In our clinical experience, decreased peristalsis of the esophagus can be observed in an underwater environment. To decrease peristalsis of the esophagus and improve the success rate of intravascular injection, we propose a method called underwater endoscopic injection sclerotherapy that requires filling up the esophageal lumen with water before sclerotherapy. A case involving a 57-year-old male patient with gastroesophageal Type 1 varices is described to illustrate the underwater endoscopic injection sclerotherapy.

  • Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

    by Shu-Qi Qin, Yu-Xin Liu, Zhen-Dan Wang, Si Da, Jing Zhou, Ke-Wei Hu, Qin-Kai Li, Guo-Jian Yin

    Gastroesophageal variceal bleeding (GEVB) is the most common complication of liver cirrhosis and the leading cause of death in patients with liver cirrhosis. Traditional endoscopic sclerotherapy has been widely used for the treatment of variceal bleeding. However, it still has a high rate of rebleeding and may cause esophageal ulceration, stricture, or perforation. Here we present a sclerotherapy method, endoscopic injection sclerotherapy assisted by cyanoacrylate and clips (CISC), as a feasible and safe procedure for gastroesophageal varices (GEVs). The method uses clips to block the oral side (outflow vein) of GEVs, lauromacrogol to sclerose the main body of GEVs, and cyanoacrylate to occlude the puncture site at the anal side (inflow vein) of GEVs. A case involving a 47-year-old male patient with GEVB is presented to illustrate the CISC procedure. In this case, CISC was effective for the treatment of gastroesophageal variceal bleeding. We propose that CISC may be considered as a first option for clinical endoscopic hemostasis.

  • JoVE Video Dataset

    by Shu-Qi Qin, Yu-Xin Liu, Zhen-Dan Wang, Si Da, Jing Zhou, Ke-Wei Hu, Qin-Kai Li, Guo-Jian Yin

    Gastroesophageal variceal bleeding (GEVB) is the most common complication of liver cirrhosis and the leading cause of death in patients with liver cirrhosis. Traditional endoscopic sclerotherapy has been widely used for the treatment of variceal bleeding. However, it still has a high rate of rebleeding and may cause esophageal ulceration, stricture, or perforation. Here we present a sclerotherapy method, endoscopic injection sclerotherapy assisted by cyanoacrylate and clips (CISC), as a feasible and safe procedure for gastroesophageal varices (GEVs). The method uses clips to block the oral side (outflow vein) of GEVs, lauromacrogol to sclerose the main body of GEVs, and cyanoacrylate to occlude the puncture site at the anal side (inflow vein) of GEVs. A case involving a 47-year-old male patient with GEVB is presented to illustrate the CISC procedure. In this case, CISC was effective for the treatment of gastroesophageal variceal bleeding. We propose that CISC may be considered as a first option for clinical endoscopic hemostasis.

  • Open Access

    The effect of blood glucose levels on serum triglyceride clearance in patients with hyperlipidemic acute pancreatitis

    by Yuxin Liu, Shuqi Qin, Si Dai, Jing Zhou, Zhendan Wang, Guojian Yin

    Preventing moderately severe and severe acute pancreatitis (MSAP & SAP) is the primary goal of the management of hyperlipidemic acute pancreatitis (HLAP). The main aim of this study was to investigate the factors affecting serum triglyceride (TG) clearance, particularly blood glucose (GLU) levels, which could potentially help to prevent the development of MSAP & SAP. The clinical data from 177 patients with MSAP & SAP and 195 patients with mild acute pancreatitis (MAP) on days 1–6 after the onset were collected and analyzed by multivariate logistic regression to identify the factors that have an impact on the severity of HLAP, especially TG. The optimal TG threshold was obtained by receiver operating characteristic (ROC) analysis to differentiate TG fast-clearance patients from TG slow-clearance patients, as defined in this study. Metabolism-related factors that may interfere with TG clearance, such as GLU, diabetes mellitus (DM), obesity, and uric acid, were further analyzed. Day 2 TG was an independent risk factor for MSAP & SAP in patients with HLAP (OR: 3.718, 95% CI: 2.042–6.77; P < 0.001). And patients with TG slow-clearance (day 2 TG ≥ 7.335 mmol/L) were more likely to develop MSAP & SAP (sensitivity 0.932, specificity 0.898), severe pancreatic necrosis, and death. DM (OR: 3.574, 95% CI: 1.13–11.308, P < 0.001) and day 2 GLU (OR: 1.537, 95% CI: 1.292–1.675; P < 0.001) were independent risk factors for TG slow-clearance but not for HLAP severity (OR: 1.728, P = 0.253 and OR: 1.119, P = 0.059). Day 2 GLU decreased below 13.07 mmol/L and 6.575 mmol/L in patients with DM and non-diabetes mellitus (NDM), respectively, contributing to the reduction of day 2 TG to 7.335 mmol/L. Day 2 TG levels had the most impact on the severity of HLAP, which also accurately predicted the occurrence of MSAP & SAP. It is worth noting whether the GLU can reach the target value on day 2, as it can directly affect the TG clearance rate and indirectly affect the severity of HLAP.


  • A nomogram to predict the occurrence of pseudocyst in patients with acute pancreatitis

    by Fengjie Ji, Wen Tang, Wen Yan, Jiujing Huang, Yuxin Liu, Jing Zhou, Shuqi Qin, Si Dai, Yulin Ji, Guojian Yin


  • Open Access

    The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis

    by Yuxin Liu, Si Dai, Shuqi Qin, Jing Zhou, Zhendan Wang, Guojian Yin

    Background and aims: To study the role of gene mutations in the development of severe hypertriglyceridemia (HTG) in patients with hyperlipidemic acute pancreatitis (HLAP), especially different apolipoprotein A5 (APOA5) mutations.Methods: Whole-exome sequencing was performed on 163 patients with HLAP and 30 patients with biliary acute pancreatitis (BAP). The pathogenicity of mutations was then assessed by combining clinical information, predictions of bioinformatics programs, information from multiple gene databases, and residue location and conservation. The pathogenic mutations ofAPOA5were visualized using the software.Results: 1. Compared with BAP patients, pathogenic mutations ofAPOA5were frequent in HLAP patients; among them, the heterozygous mutation of p.G185C was the most common.2. All six pathogenic mutations ofAPOA5identified in this study (p.S35N, p.D167V, p.G185C, p.K188I, p.R223C, and p.H182fs) were positively correlated with severe HTG; they were all in the important domains of apolipoprotein A-V (apoA-V). Residue 223 is strictly conserved in multiple mammals and is located in the lipoprotein lipase (LPL)-binding domain (Pro215–Phe261). When Arg 223 is mutated to Cys 223, the positive charge of this residue is reduced, which is potentially destructive to the binding function of apoA-V to LPL.3. Four newAPOA5mutations were identified, namely c.563A > T, c.667C > T, c.788G > A, and c.544_545 insGGTGC.Conclusions: The pathogenic mutations ofAPOA5were specific to the patients with HLAP and severe HTG in China, and identifying such mutations had clinical significance in elucidating the etiology and subsequent treatment.Graphical


  • Open Access

    The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis

    by Yuxin Liu, Si Dai, Shuqi Qin, Jing Zhou, Zhendan Wang, Guojian Yin

    Background and aims: To study the role of gene mutations in the development of severe hypertriglyceridemia in patients with hyperlipidemic acute pancreatitis (HLAP), especially different APOA5 mutations. Methods: Whole exome sequencing was performed on 163 patients with HLAP and 30 patients with biliary acute pancreatitis (BAP). The products of pathogenic mutations in APOA5were visualized using software simulations. The clinical data of the patients were also collected and analyzed. Results: 1. Compared with BAP patients, pathogenic mutations of APOA5 were frequent in HLAP patients; among them, heterozygous mutation of p.G185C was the most common. 2. All six pathogenic mutations of APOA5 identified in this study (p.S35N, p.D167V, p.G185C, p.K188I, p.R223C, p.H182fs) were positively correlated with severe hypertriglyceridemia; they were all in the important domains of apolipoprotein A-V (apoA-V). p.R223C has the potential to be one of the most deleterious mutations to apoA-V, considering the specific position of residue 223 and the altered amino acid property. 3. Four new APOA5 mutations were identified, namely c.563A>T, c.667C>T, c.788G>A and c.544_545 insGGTGC. Conclusions: The pathogenic mutations of APOA5 were specific to the HLAP patients with severe hypertriglyceridemia in China, and identifying such mutations had clinical significance in elucidating the etiology and subsequent treatment.

  • Comparison of different intensive triglyceride-lowering therapies in patients with hyperlipidemic acute pancreatitis

    by Wan Pu, Wen Tang, Yaoliang Shen, Fengjie Ji, Jiujing Huang, Yuxin Liu, Jing Zhou, Guojian Yin